Mental health problems and hypertension in the elderly: Review from the HOPE Asia Network

Yuda Turana, Jeslyn Tengkawan, Yook C. Chia, Jinho Shin, Chen Huan Chen, Sungha Park, Kelvin Tsoi, Peera Buranakitjaroen, Arieska A. Soenarta, Saulat Siddique, Hao Min Cheng, Jam C. Tay, Boon W. Teo, Tzung Dau Wang, Kazuomi Kario

Research output: Contribution to journalReview articlepeer-review

7 Citations (Scopus)


The “triple burden” of aging population, hypertension, and mental health problems making elderly in Asia is more vulnerable. There is evidence of a bidirectional relationship between mental health and hypertension, which results in lower quality of life, lower rate of treatment adherence, and higher mortality among elderly individuals. It is essential to overcome known barriers and care for the elderly with high-risk factors in order to address these burdens. This review revealed that elderly with hypertension were more likely to suffer from depression and anxiety. Therefore, debunking myths, creating awareness regarding mental health, and increasing access to mental health resources through holistic community-based programs would greatly reduce such problems and optimize the chances of success in controlling hypertension-related problems.

Original languageEnglish
Pages (from-to)504-512
Number of pages9
JournalJournal of Clinical Hypertension
Issue number3
Publication statusPublished - 2021 Mar

Bibliographical note

Funding Information:
YC Chia has received speakers’ honorarium and sponsorship to attend conferences and CME seminars from Abbott, Bayer, Boehringer Ingelheim Pharmaceuticals, GlaxoSmithKline, Menarini, Merck Sharp & Dohme, Novartis, Omron, Pfizer, and Sanofi and Xepa‐Soul Pattinson, and a research grant from Pfizer Inc J Shin has received lecture honoraria from Pfizer Inc, Hanmi Pharm. Co. Ltd., Yuhan Co. Ltd., Boryung Pharmaceutical Co. Ltd., consulting fees from Hanmi Pharm. Co. Ltd., and research grants from Sanofi Pharm. and Hanmi Pharm. Co. Ltd. CH Chen reports personal fees from Novartis, Sanofi, Daiichi Sankyo, Servier, and Boehringer Ingelheim Pharmaceuticals Inc S Park has received honoraria from Pfizer Inc, Daiichi Sankyo, Takeda Pharmaceuticals International, Daewon Pharmaceutical Company, Boryung Pharmaceutical Company, and Servier. S Park has also received a research grant from Daiichi Sankyo. S Siddique has received honoraria from Bayer, Novartis, Pfizer Inc, ICI, and Servier, and travel, accommodation, and conference registration support from Hilton Pharma, Atco Pharmaceutical, Highnoon Laboratories, Horizon Pharma, and ICI. HM Cheng has received speakers’ honorarium and sponsorship to attend conferences and CME seminars from Eli Lilly and AstraZeneca; Pfizer Inc, Bayer AG, Boehringer Ingelheim Pharmaceuticals Inc, Daiichi Sankyo, Novartis Pharmaceuticals Inc Servier, Sanofi, and Takeda Pharmaceuticals International, and has served as an advisor or consultant for ApoDx Technology Inc K Kario received a research grant from MSD K.K, Astellas Pharma Inc, Eisai Co., Otsuka Pharmaceutical Co., Sanwa Kagaku Kenkyusho Co., Daiichi Sankyo Co., Taisho Pharmaceutical Co., Ltd., Sumitomo Dainippon Pharma Co., Takeda Pharmaceutical Co., Teijin Pharma, Boehringer Ingelheim Japan Inc, Bristol‐Myers Squibb K.K, and Mochida Pharmaceutical Co. Ltd., and honoraria from Daiichi Sankyo Co. Ltd. and Mylan EPD. All other authors report no potential conflicts of interest in relation to this article.

Publisher Copyright:
© 2020 The Authors. The Journal of Clinical Hypertension published by Wiley Periodicals LLC

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Mental health problems and hypertension in the elderly: Review from the HOPE Asia Network'. Together they form a unique fingerprint.

Cite this